Statistics for PERSEPT 3 A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta recombinant human FVIIa in perioperative care in subjects with haemophilia A or B with inhibitors

Total visits

views
PERSEPT 3 A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta recombinant human FVIIa in perioperative care in subjects with haemophilia A or B with inhibitors 2

Total visits per month

views
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0
August 2024 0

File Visits

views
Journal.pdf 3

Top country views

views
South Africa 2

Top city views

views
Johannesburg 1
Midrand 1